Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare

Translated title of the contribution: Efficacy of an aluminum salts thermofobic foam in the treatment of axillary and palmar primary hyperidrosis

D. Innocenzi, F. Lupi, F. Bruni, M. Frasca, C. Panetta, M. Milani

Research output: Contribution to journalArticle

Abstract

Background: Primary or idiophatic hyperhidrosis (PH) is a chronic disorder of excessive eccrine sweating that mainly affects the axillae, the palms, the soles of the feet, and the face. The treatment options for PH involve a range of topical or systemic medications and/or surgical invasive techniques. Common topical treatments are aluminium salts that act by blocking the duct of the eccrine gland. Recently, a new low-residues thermophobic foam formulation containing 20% aluminium salts (sesquichlorhydrate) has been developped (R&D Mipharm, Milan, Italy). The foam formulation is easy to apply expecially in hairy body sites. Study Aim: The aim of this study was to evaluate the effectiveness of this new aluminum salts thermophobic foam in the treatment of axillary and palmar PH. Patients and Methods: In a single center, open-label, follow-up study, 19 patients affected by PH were enrolled. Minor test score and Dermatology Life Quality Index (DLQI) were utilized to evaluate amount and the impact on quality of life. The foam was applied to the dry and clean skin, every night during the first week and three times during the second week. The evaluation of the results was performed by patients' subjective reports (DLQI) collected at baseline, at 7 and 15 days after treatment; and by the objective comparison of Minor test at baseline, at 7 and 15 days after treatment. Patients were monitored throughout the study for adverse events. Results: All of the 19 enrolled patients completed the study. The foam induced a significant reduction of the Minor score in comparison with baseline values in both axillary (p=0.0002) and palm region (p=0.0047), The foam shows a positive impact in DLQI mainly in patients with axillary hyperhidrosis. No side effects were reported during the entire study duration by patients. Conclusion: This new foam has shown to be an effective topical treatment in reducing sweating in patients with primary axillary and palm hyperhidrosis. This formulation is well tolerated in the short term. Further studies are warranted to evaluate efficacy and safety in the medium and long term.

Original languageItalian
Pages (from-to)131-135
Number of pages5
JournalDermatologia Clinica
Volume25
Issue number3
Publication statusPublished - Jul 2005

Fingerprint

Aluminum
Salts
Hyperhidrosis
Dermatology
Quality of Life
Sweating
Therapeutics
Eccrine Glands
Axilla
Italy
Foot
Safety
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Innocenzi, D., Lupi, F., Bruni, F., Frasca, M., Panetta, C., & Milani, M. (2005). Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare. Dermatologia Clinica, 25(3), 131-135.

Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare. / Innocenzi, D.; Lupi, F.; Bruni, F.; Frasca, M.; Panetta, C.; Milani, M.

In: Dermatologia Clinica, Vol. 25, No. 3, 07.2005, p. 131-135.

Research output: Contribution to journalArticle

Innocenzi, D, Lupi, F, Bruni, F, Frasca, M, Panetta, C & Milani, M 2005, 'Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare', Dermatologia Clinica, vol. 25, no. 3, pp. 131-135.
Innocenzi, D. ; Lupi, F. ; Bruni, F. ; Frasca, M. ; Panetta, C. ; Milani, M. / Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare. In: Dermatologia Clinica. 2005 ; Vol. 25, No. 3. pp. 131-135.
@article{158d3168c6164c72b32186d728e8c508,
title = "Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare",
abstract = "Background: Primary or idiophatic hyperhidrosis (PH) is a chronic disorder of excessive eccrine sweating that mainly affects the axillae, the palms, the soles of the feet, and the face. The treatment options for PH involve a range of topical or systemic medications and/or surgical invasive techniques. Common topical treatments are aluminium salts that act by blocking the duct of the eccrine gland. Recently, a new low-residues thermophobic foam formulation containing 20{\%} aluminium salts (sesquichlorhydrate) has been developped (R&D Mipharm, Milan, Italy). The foam formulation is easy to apply expecially in hairy body sites. Study Aim: The aim of this study was to evaluate the effectiveness of this new aluminum salts thermophobic foam in the treatment of axillary and palmar PH. Patients and Methods: In a single center, open-label, follow-up study, 19 patients affected by PH were enrolled. Minor test score and Dermatology Life Quality Index (DLQI) were utilized to evaluate amount and the impact on quality of life. The foam was applied to the dry and clean skin, every night during the first week and three times during the second week. The evaluation of the results was performed by patients' subjective reports (DLQI) collected at baseline, at 7 and 15 days after treatment; and by the objective comparison of Minor test at baseline, at 7 and 15 days after treatment. Patients were monitored throughout the study for adverse events. Results: All of the 19 enrolled patients completed the study. The foam induced a significant reduction of the Minor score in comparison with baseline values in both axillary (p=0.0002) and palm region (p=0.0047), The foam shows a positive impact in DLQI mainly in patients with axillary hyperhidrosis. No side effects were reported during the entire study duration by patients. Conclusion: This new foam has shown to be an effective topical treatment in reducing sweating in patients with primary axillary and palm hyperhidrosis. This formulation is well tolerated in the short term. Further studies are warranted to evaluate efficacy and safety in the medium and long term.",
keywords = "Aluminium salts, Idiopathic hyperhidrosis, Thermophobic foam",
author = "D. Innocenzi and F. Lupi and F. Bruni and M. Frasca and C. Panetta and M. Milani",
year = "2005",
month = "7",
language = "Italian",
volume = "25",
pages = "131--135",
journal = "Dermatologia Clinica",
issn = "0392-1395",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "3",

}

TY - JOUR

T1 - Efficacia di una mousse termosensibile ai sali d'alluminio nel trattamento dell'iperidrosi idiopatica ascellare e palmare

AU - Innocenzi, D.

AU - Lupi, F.

AU - Bruni, F.

AU - Frasca, M.

AU - Panetta, C.

AU - Milani, M.

PY - 2005/7

Y1 - 2005/7

N2 - Background: Primary or idiophatic hyperhidrosis (PH) is a chronic disorder of excessive eccrine sweating that mainly affects the axillae, the palms, the soles of the feet, and the face. The treatment options for PH involve a range of topical or systemic medications and/or surgical invasive techniques. Common topical treatments are aluminium salts that act by blocking the duct of the eccrine gland. Recently, a new low-residues thermophobic foam formulation containing 20% aluminium salts (sesquichlorhydrate) has been developped (R&D Mipharm, Milan, Italy). The foam formulation is easy to apply expecially in hairy body sites. Study Aim: The aim of this study was to evaluate the effectiveness of this new aluminum salts thermophobic foam in the treatment of axillary and palmar PH. Patients and Methods: In a single center, open-label, follow-up study, 19 patients affected by PH were enrolled. Minor test score and Dermatology Life Quality Index (DLQI) were utilized to evaluate amount and the impact on quality of life. The foam was applied to the dry and clean skin, every night during the first week and three times during the second week. The evaluation of the results was performed by patients' subjective reports (DLQI) collected at baseline, at 7 and 15 days after treatment; and by the objective comparison of Minor test at baseline, at 7 and 15 days after treatment. Patients were monitored throughout the study for adverse events. Results: All of the 19 enrolled patients completed the study. The foam induced a significant reduction of the Minor score in comparison with baseline values in both axillary (p=0.0002) and palm region (p=0.0047), The foam shows a positive impact in DLQI mainly in patients with axillary hyperhidrosis. No side effects were reported during the entire study duration by patients. Conclusion: This new foam has shown to be an effective topical treatment in reducing sweating in patients with primary axillary and palm hyperhidrosis. This formulation is well tolerated in the short term. Further studies are warranted to evaluate efficacy and safety in the medium and long term.

AB - Background: Primary or idiophatic hyperhidrosis (PH) is a chronic disorder of excessive eccrine sweating that mainly affects the axillae, the palms, the soles of the feet, and the face. The treatment options for PH involve a range of topical or systemic medications and/or surgical invasive techniques. Common topical treatments are aluminium salts that act by blocking the duct of the eccrine gland. Recently, a new low-residues thermophobic foam formulation containing 20% aluminium salts (sesquichlorhydrate) has been developped (R&D Mipharm, Milan, Italy). The foam formulation is easy to apply expecially in hairy body sites. Study Aim: The aim of this study was to evaluate the effectiveness of this new aluminum salts thermophobic foam in the treatment of axillary and palmar PH. Patients and Methods: In a single center, open-label, follow-up study, 19 patients affected by PH were enrolled. Minor test score and Dermatology Life Quality Index (DLQI) were utilized to evaluate amount and the impact on quality of life. The foam was applied to the dry and clean skin, every night during the first week and three times during the second week. The evaluation of the results was performed by patients' subjective reports (DLQI) collected at baseline, at 7 and 15 days after treatment; and by the objective comparison of Minor test at baseline, at 7 and 15 days after treatment. Patients were monitored throughout the study for adverse events. Results: All of the 19 enrolled patients completed the study. The foam induced a significant reduction of the Minor score in comparison with baseline values in both axillary (p=0.0002) and palm region (p=0.0047), The foam shows a positive impact in DLQI mainly in patients with axillary hyperhidrosis. No side effects were reported during the entire study duration by patients. Conclusion: This new foam has shown to be an effective topical treatment in reducing sweating in patients with primary axillary and palm hyperhidrosis. This formulation is well tolerated in the short term. Further studies are warranted to evaluate efficacy and safety in the medium and long term.

KW - Aluminium salts

KW - Idiopathic hyperhidrosis

KW - Thermophobic foam

UR - http://www.scopus.com/inward/record.url?scp=30644472657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30644472657&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:30644472657

VL - 25

SP - 131

EP - 135

JO - Dermatologia Clinica

JF - Dermatologia Clinica

SN - 0392-1395

IS - 3

ER -